Avanos Recalls Ballard Closed Suction Systems
Due to sterilization failureMay result in non-sterile devices
Avanos Medical, Inc. is recalling its Ballard Closed Suction Systems after identifying a failure in the sterilization process, which may result in non-sterile devices. Use of these products could lead to serious health risks, including infection, airway injury, inflammation, sepsis, or death.
No injuries or deaths have been reported to date.
About the Device
The Ballard Closed Suction System is used for removing airway secretions in ventilated patients, helping to maintain ventilation without disconnecting the circuit — a critical function in respiratory care.
Recommended Actions (as of March 19, 2025)
- Immediately stop using any affected products and quarantine them.
- Check your inventory for affected items listed in the recall notice.
- Notify any customers or departments you may have shared the product with.
- Complete and return the Response Form to: productquality@myairlife.com.
- Arrange for return or confirm destruction of affected units to receive replacements.
- Communicate the recall to all relevant staff within your organization.
- For urgent replacement needs, contact AirLife at 1-800-433-2797.
Need Help?
For questions or support related to the recall, contact Avanos Medical, Inc. at 1-800-433-2797.
Healthcare providers are urged to act promptly to prevent potential harm to patients relying on these critical airway management systems.
Affected Products
Affected Product
Product Names:
- Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Y-Adapter
- Ballard Closed Suction System for Neonates/Pediatrics, 10 F, Elbow
- Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Elbow
- Ballard Closed Suction System for Adults, 14 F, T-Piece
- Ballard Closed Suction System for Adults, 14 F, DSE
- Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE, MDI
- Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE
Click here to see a full list of affected devices.
Abiomed Issues Correction for Automated Impella Controllers
Hardware Updates Required to Address Potential Loss of Hemodynamic Support Abiomed has issued a correction for certain Automated Impella Controllers (AICs) used with the Impella heart pump system after identifying hardware-related issues that could lead to controller...
FDA Clears First OTC Continuous Glucose Monitor for Children
Regulatory Snapshot Device: Stelo® Glucose Biosensor System (Dexcom, Inc.)Indication: Continuous glucose monitoring for individuals ages 2 years and older who do not use insulin, including children with diabetes managed through oral medications and individuals seeking...
FDA Early Alert for Baxter Pressure Breathing Device
FDA Issues Early Alert for Baxter Volara System Patient Circuits Following Therapy Leakage Concerns The U.S. Food and Drug Administration (FDA) has issued an Early Alert regarding a potentially high-risk issue affecting certain Baxter Volara System patient circuits...